GSA Capital Partners’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-379,244	Closed	-$1.24M	–	1929
2021 Q3	$1.24M	Buy	379,244 +98,635	+35%	+$323K	0.13%	207
2021 Q2	$1.18M	Buy	280,609 +162,360	+137%	+$685K	0.13%	180
2021 Q1	$590K	Buy	118,249 +46,622	+65%	+$233K	0.1%	267
2020 Q4	$905K	Buy	71,627 +13,532	+23%	+$171K	0.15%	159
2020 Q3	$570K	Buy	58,095 +40,744	+235%	+$400K	0.1%	312
2020 Q2	$173K	Buy	+17,351	New	+$173K	0.1%	383
2020 Q1	–	Sell	-48,565	Closed	-$448K	–	1689
2019 Q4	$448K	Buy	48,565 +12,470	+35%	+$115K	0.05%	730
2019 Q3	$212K	Buy	+36,095	New	+$212K	0.03%	1144
2019 Q2	–	Sell	-74,820	Closed	-$903K	–	1817
2019 Q1	$903K	Sell	74,820 -19,080	-20%	-$230K	0.09%	343
2018 Q4	$1.18M	Sell	93,900 -77,600	-45%	-$974K	0.14%	156
2018 Q3	$2.55M	Buy	171,500 +47,800	+39%	+$709K	0.14%	146
2018 Q2	$2.08M	Buy	+123,700	New	+$2.08M	0.1%	257
2018 Q1	–	Sell	-69,300	Closed	-$1.79M	–	1888
2017 Q4	$1.79M	Buy	+69,300	New	+$1.79M	0.11%	288
2017 Q2	–	Sell	-20,500	Closed	-$350K	–	2027
2017 Q1	$350K	Sell	20,500 -35,809	-64%	-$611K	0.02%	1298
2016 Q4	$579K	Buy	56,309 +3,204	+6%	+$32.9K	0.03%	900
2016 Q3	$537K	Sell	53,105 -97,643	-65%	-$987K	0.03%	1019
2016 Q2	$1.69M	Buy	150,748 +105,187	+231%	+$1.18M	0.09%	316
2016 Q1	$622K	Sell	45,561 -33,080	-42%	-$452K	0.04%	853
2015 Q4	$1.49M	Buy	78,641 +7,254	+10%	+$138K	0.07%	425
2015 Q3	$1.34M	Buy	+71,387	New	+$1.34M	0.07%	457